medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 4

<< Back Next >>

Rev Mex Pediatr 2023; 90 (4)

Dysmetabolic acrodermatitis

Rivera-Comparán EA, Santillán-García MA, Gómez-Negrete A, Peregrino-Bejarano L, Zurita-Cruz JN
Full text How to cite this article 10.35366/114767

DOI

DOI: 10.35366/114767
URL: https://dx.doi.org/10.35366/114767

Language: Spanish
References: 17
Page: 162-166
PDF size: 227.99 Kb.


Key words:

acrodermatitis, maple syrup urine disease, dermatitis, amino acids, inborn errors of metabolism.

ABSTRACT

Introduction: dysmetabolic acrodermatitis can occur in patients with inborn errors of metabolism, such as maple syrup urine disease (MSUD). Case description: this is a male patient who, at eight days of age, presented hypotonia, lethargy, anorexia, apneas and cyanosis. Due to the neurological manifestations, an inborn error of metabolism is suspected, requesting metabolic screening. Due to elevated plasma levels of leucine, isoleucine and valine, a diagnosis of MSUD was established, starting a diet free of these amino acids. At five months of age, he was identified with disseminated dermatosis: confluent erythematosquamous plaques, poorly delimited, considered as dysmetabolic acrodermatitis; after seven days of adjusting therapy, improvement of the dermatological lesions was observed. He remained stable until 2 years of age, when he was readmitted for dermatosis exacerbation and metabolic acidosis; however, the patient died despite intensive care management. Conclusions: in dysmetabolic acrodermatitis, skin lesions can be a marker of decompensation of a metabolic disease. Early identification of this complication can help offer timely treatment.


REFERENCES

  1. Sojo Aguirre A, Aldámiz-Echevarría Azuara L, Martínez Ezquerra N, Maruri Elizalde M, Sanjurjo Crespo P. Acrodermatitis seudoenteropática en la acidemia propiónica [Enteropathic-like acrodermatitis in propionic acidaemia]. An Pediatr (Barc). 2009; 70(2): 197-198.

  2. Umapathi KK, Thavamani A. Acrodermatitis dysmetabolica in phenylketonuria. Pediatr Neonatol. 2019; 60(2): 229-230.

  3. Flores K, Chikowski R, Morrell DS. Acrodermatitis dysmetabolica in an infant with maple syrup urine disease. Clin Exp Dermatol. 2016; 41(6): 651-654.

  4. Chapman KA, Gramer G, Viall S, Summar ML. Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data. Mol Genet Metab Rep. 2018; 15(2): 106-109.

  5. Ibarra-González I, Fernández-Lainez C, Belmont-Martínez L et al. Elevada mortalidad y discapacidad en niños mexicanos con enfermedad de orina con olor a jarabe de arce (EOJA). Gac Med Mex. 2007; 143(3): 197-201.

  6. Uaariyapanichkul J, Saengpanit P, Damrongphol P, Suphapeetiporn K, Chomtho S. Skin lesions associated with nutritional management of maple syrup urine disease. Case Rep Dermatol Med. 2017; 2017: 3905658.

  7. Simon E, Flaschker N, Schadewaldt P, Langenbeck U, Wendel U. Variant maple syrup urine disease (MSUD)--the entire spectrum. J Inherit Metab Dis. 2006; 29(6): 716-724.

  8. Blackburn PR, Gass JM, Vairo FPE, Farnham KM, Atwal HK, Macklin S, Klee EW, Atwal PS. Maple syrup urine disease: mechanisms and management. Appl Clin Genet. 2017; 10: 57-66.

  9. Tabanlioglu D, Ersoy-Evans S, Karaduman A. Acrodermatitis enteropathica-like eruption in metabolic disorders: acrodermatitis dysmetabolica is proposed as a better term. Pediatr Dermatol. 2009; 26(2): 150-154.

  10. Vitoria Miñana I, Dalmau Serra J. Lesiones semejantes a las acrodermatitis enteropática en la acidemia metilmalónica por déficit de valina [Enteropathic acrodermatitis-like lesions in valine deficiency methylmalonic acidaemia]. An Pediatr (Barc). 2010; 72(1): 96-97.

  11. Rosa J, Fraga AB, de Carvalho R, Maia AL, Rodrigues AL, Gomes MF. Acrodermatitis dysmetabolica as a sign of methylmalonic aciduria decompensation. Clin Case Rep. 2018; 6(6): 1048-1050.

  12. Ross B, Kumar M, Srinivasan H, Ekbote AV. Isoleucine deficiency in a neonate treated for maple syrup urine disease masquerading as acrodermatitis enteropathica. Indian Pediatr. 2016; 53(8): 738-740.

  13. Dominguez-Cruz J, Bueno-Delgado M, Bernabeu-Wittel J, Delgado-Pecellin C, Conejo-Mir J. Acrodermatitis acidemica: experience of 5 years in Andalusia. Pediatr Dermatol. 2010; 27(2): 218-219.

  14. Bodemer C, De Prost Y, Bachollet B, Poggi F, Teillac-Hamel D, Fraitag S, Saudubray JM. Cutaneous manifestations of methylmalonic and propionic acidaemia: a description based on 38 cases. Br J Dermatol. 1994; 131(1): 93-98.

  15. Gupta N, Jain P, Kabra M, Gulati S, Sethuraman G. Acrodermatitis dysmetabolica--report of two cases. Indian J Pediatr. 2015; 82(9): 869-870.

  16. Maguire CA, Chong H, Ramachandran R, Popoola J, Akhras V, Singh M. Acrodermatitis acidaemica. Clin Exp Dermatol. 2018; 43(3): 315-318.

  17. Campuzano-García AE, Castanedo-Cázares JP. Nutritional deficiency dermatitis related to branched-chain amino acid restriction in a child with maple syrup urine disease. Dermatol Online J. 2019; 25(9): 13030/qt53k0s8f7.




Figure 1
Table 1

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2023;90